FIBROMAX

Collection Instr. …………: 12-hour fast recommended.

Inform Weight and Height to the collector.

Technical information: Composed of the ASH TEST, NASH TEST, FIBRO TEST, ACTI TEST and STEATO TEST, as describedabove, this profile provides a rich and non-invasive liver analysis, providing the possibility of early diagnosis and prevention of pathological prognosis. 

AshTest is a faster procedure for concluding cases of Acute Steatohepatitis (ASH), and provides an important tool for developing therapies to treat the disease, in order to seek case improvement and alternatives to liver transplantation, an extreme measure in some cases.

NashTest evaluates the presence or absence of Non-Alcoholic Hepatic Steatosis and, when combined with the performance of FibroTest, is able to demonstrate the value of Nash screening in patients with metabolic risk factors.

FibroTest is a test that is highly recommended by health authorities around the world. The test is intended to measure levels of liver fibrosis and cirrhosis, and is the only study that can classify the early stages of fibrosis.

With ActiTest, together with FibroTest, it is possible to identify asymptomatic carriers of Hepatitis B and to detect more effective treatments, and it is essential to evaluate the progression of this disease.

SteatoTest measures the level of steatosis in the body, which is the increased accumulation of fat in the liver. The test is primarily targeted at patients who are at high metabolic risk, excessive alcohol consumers, or chronic carriers of hepatitis B or C. With this quantitative steatosis test, it is possible to monitor patients in order to follow the progression or regression of the case, offering the professional who attends them a tool to develop treatments that will enable the normalization of this condition.